Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* women 16 or older in UK(except Northern Ireland) sites, 17 years or more in Northern Ireland (UK) and 18 years or more in Ireland and US~* present within 120 hours of unprotected intercourse~* regular menstrual cycles~* No current use of hormonal contraception~* Willing to not use hormonal methods of contraception until study completion~* At least one complete menstrual cycle (2 menses) post miscarriage, delivery or abortion~* For women who present more than 72 hours after intercourse, decline the insertion of an Intra Uterine Device for emergency contraception~* Able to provide informed consent~* Willing to abstain from further acts of unprotected intercourse until study completion~Exclusion Criteria:~* One or more acts of unprotected intercourse more than 120 hours~* current or recent use of hormonal methods of contraception~* currently pregnant or breastfeeding~* tubal ligation or current use of IUD~* Use of hormonal emergency contraception since last menstrual period~* Current use of IUD~* Tubal ligation~* Partner with a vasectomy~* Unsure about the date of the last menstrual period~* Severe asthma insufficiently controlled by oral glucocorticoid~* Hypersensitivity to the active substance levonorgestrel or any of the excipients of the drug products used in the study

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CDB-2914 (Type: EXPERIMENTAL): None
- Levonorgestrel (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).